Liu Y - Search Results

1

Design, synthesis and biological evaluation of fluorinated selective estrogen receptor degraders (FSERDs) --- A promising strategy for advanced ER positive breast cancer.

Lu Y, Liu C, Wang X, Liu L, Zhao Z, Liang Z, Liu Y, Wen Z, Du Q, Liu W. Lu Y, et al. Among authors: liu y, liu l, liu c, liu w. Eur J Med Chem. 2023 May 5;253:115324. doi: 10.1016/j.ejmech.2023.115324. Epub 2023 Mar 30. Eur J Med Chem. 2023. PMID: 37019030

2

A Gold(I) Complex Containing an Oleanolic Acid Derivative as a Potential Anti-Ovarian-Cancer Agent by Inhibiting TrxR and Activating ROS-Mediated ERS.

Bian M, Sun Y, Liu Y, Xu Z, Fan R, Liu Z, Liu W. Bian M, et al. Among authors: liu z, liu y, liu w. Chemistry. 2020 Jun 2;26(31):7092-7108. doi: 10.1002/chem.202000045. Epub 2020 Mar 25. Chemistry. 2020. PMID: 32037581

3

Discovery of Potential Flavonoid Inhibitors Against COVID-19 3CL Proteinase Based on Virtual Screening Strategy.

Xu Z, Yang L, Zhang X, Zhang Q, Yang Z, Liu Y, Wei S, Liu W. Xu Z, et al. Among authors: liu y, liu w. Front Mol Biosci. 2020 Sep 29;7:556481. doi: 10.3389/fmolb.2020.556481. eCollection 2020. Front Mol Biosci. 2020. PMID: 33134310 Free PMC article.

4

Repurposing of the gold drug auranofin and a review of its derivatives as antibacterial therapeutics.

Liu Y, Lu Y, Xu Z, Ma X, Chen X, Liu W. Liu Y, et al. Among authors: liu w. Drug Discov Today. 2022 Jul;27(7):1961-1973. doi: 10.1016/j.drudis.2022.02.010. Epub 2022 Feb 19. Drug Discov Today. 2022. PMID: 35192926 Review.

5

Heteroleptic Gold(I)-bisNHC complex with excellent activity in vitro, ex vivo and in vivo against endometrial cancer.

Xiao Q, Liu Y, Jiang G, Liu Y, Huang Y, Liu W, Zhang Z. Xiao Q, et al. Among authors: liu y, liu w. Eur J Med Chem. 2022 Jun 5;236:114302. doi: 10.1016/j.ejmech.2022.114302. Epub 2022 Mar 29. Eur J Med Chem. 2022. PMID: 35395440

6

NSAID-Au(I) Complexes Induce ROS-Driven DAMPs and Interpose Inflammation to Stimulate the Immune Response against Ovarian Cancer.

Xu Z, Lu Q, Shan M, Jiang G, Liu Y, Yang Z, Lu Y, Liu W. Xu Z, et al. Among authors: liu y, liu w. J Med Chem. 2023 Jun 22;66(12):7813-7833. doi: 10.1021/acs.jmedchem.3c00063. Epub 2023 Jun 8. J Med Chem. 2023. PMID: 37291753

7

A terbium(III) complex-based time-resolved luminescent probe for selenocysteine as an inhibitor of selenoproteins.

Chen J, Gao F, Xu Z, Liu Y, Hu M, Yuan C, Zhang Y, Liu W, Wang X. Chen J, et al. Among authors: liu y, liu w. Chem Commun (Camb). 2024 Feb 1;60(11):1440-1443. doi: 10.1039/d3cc05680e. Chem Commun (Camb). 2024. PMID: 38206371

8

Altered cerebral gray matter volume and functional connectivity in patients with residual dizziness of benign paroxysmal positional vertigo.

Liu D, Lin C, Sun Y, Shen S, Xiao L, Chen Z, Liu Y, Liu T, Rong L. Liu D, et al. Among authors: liu y. Clin Radiol. 2024 Dec 19;82:106780. doi: 10.1016/j.crad.2024.106780. Online ahead of print. Clin Radiol. 2024. PMID: 39854796

9

Correlative Raman-Voltage Microscopy Revealing the Localized Structure-Stress Relationship in Silicon Solar Cells.

Lan T, Zhao T, Liu Y, Cao J, Li W, Yang J, Zhang X, Wang Y, Sun B. Lan T, et al. Among authors: liu y. ACS Nano. 2025 Jan 24. doi: 10.1021/acsnano.4c13688. Online ahead of print. ACS Nano. 2025. PMID: 39854730

10

Establishment of critical values for AMH screening with PCOS based on restricted cubic spline plots.

Wang Z, Teng X, Shen Y, Liu Y. Wang Z, et al. Among authors: liu y. Endocr Connect. 2025 Jan 1:EC-24-0522. doi: 10.1530/EC-24-0522. Online ahead of print. Endocr Connect. 2025. PMID: 39854723

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

210,343 results

Search Page

Filters